Clinical trial
Adenosine Receptors From Genes to Behavior: Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance, Decision-Making and Interoception in Healthy Individuals and Panic Disorder.
NCT06145490 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adenosine Receptors From Genes to Behavior: Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance, Decision-Making and Interoception in Healthy Individuals and Panic Disorder.
- Lead sponsor
- Uppsala University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 29, 2024
- Completion date
- May 15, 2025
- Enrollment
- 42 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, panic disorder